These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35972892)

  • 1. METTL3-induced DLGAP1-AS2 promotes non-small cell lung cancer tumorigenesis through m
    Zhang Q; Zhang Y; Chen H; Sun LN; Zhang B; Yue DS; Wang CL; Zhang ZF
    Cell Cycle; 2022 Dec; 21(24):2602-2614. PubMed ID: 35972892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA DLGAP1-AS2 regulates miR-503/cyclin D1 to promote cell proliferation in non-small cell lung cancer.
    Wang L; Tang L; Ge T; Zhu F; Liu D; Guo H; Qian P; Xu N
    BMC Pulm Med; 2021 Aug; 21(1):277. PubMed ID: 34454450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DLGAP1-AS2 promotes human colorectal cancer progression through trans-activation of Myc.
    Ren C; Han H; Pan J; Chang Q; Wang W; Guo X; Bian J
    Mamm Genome; 2022 Dec; 33(4):672-683. PubMed ID: 36222892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA DLGAP1-AS2 promotes tumorigenesis and metastasis by regulating the Trim21/ELOA/LHPP axis in colorectal cancer.
    Wang X; Cheng H; Zhao J; Li J; Chen Y; Cui K; Tian L; Zhang J; Li C; Sun S; Feng Y; Yao S; Bian Z; Huang S; Fei B; Huang Z
    Mol Cancer; 2022 Nov; 21(1):210. PubMed ID: 36376892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The knockdown of lncRNA DLGAP1-AS2 suppresses osteosarcoma progression by inhibiting aerobic glycolysis via the miR-451a/HK2 axis.
    Zheng C; Li R; Zheng S; Fang H; Xu M; Zhong L
    Cancer Sci; 2023 Dec; 114(12):4747-4762. PubMed ID: 37817462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The m6A modification-mediated positive feedback between glycolytic lncRNA SLC2A1-DT and c-Myc promotes tumorigenesis of hepatocellular carcinoma.
    Zeng Z; Wang J; Xu F; Hu P; Hu Y; Zhuo W; Chen D; Han S; Wang F; Zhao Y; Huang Y; Zhao G
    Int J Biol Sci; 2024; 20(5):1744-1762. PubMed ID: 38481809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA DLGAP1-AS1 modulates the development of non-small-cell lung cancer via the microRNA-193a-5p/DTL axis.
    Pan X; Chen S; Ye L; Xu S; Wang L; Sun Y
    Lab Invest; 2022 Nov; 102(11):1182-1191. PubMed ID: 36183046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. m
    Xue L; Li J; Lin Y; Liu D; Yang Q; Jian J; Peng J
    J Cell Physiol; 2021 Apr; 236(4):2649-2658. PubMed ID: 32892348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Non-coding RNA DLGAP1-AS1 and DLGAP1-AS2: Two Novel Oncogenes in Multiple Cancers.
    Zhao F; Tan F; Tang L; Du Z; Chen X; Yang Y; Zhou G; Yuan C
    Curr Med Chem; 2023; 30(25):2822-2834. PubMed ID: 36121088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA DLGAP1-AS2 overexpression associates with gastric tumorigenesis: a promising diagnostic and therapeutic target.
    Soltani R; Amini M; Mazaheri Moghaddam M; Jebelli A; Ahmadiyan S; Bidar N; Baradaran B; MotieGhader H; Asadi M; Mokhtarzadeh A
    Mol Biol Rep; 2022 Jul; 49(7):6817-6826. PubMed ID: 34981339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p/c-Myc axis.
    Hua Q; Jin M; Mi B; Xu F; Li T; Zhao L; Liu J; Huang G
    J Hematol Oncol; 2019 Sep; 12(1):91. PubMed ID: 31488218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL3-stabilized lncRNA SNHG7 accelerates glycolysis in prostate cancer via SRSF1/c-Myc axis.
    Liu J; Yuan JF; Wang YZ
    Exp Cell Res; 2022 Jul; 416(1):113149. PubMed ID: 35405116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DLGAP1-AS2 promotes estrogen receptor signalling and confers tamoxifen resistance in breast cancer.
    Liang X; Zhao Y; Fang Z; Shao N; Zhai D; Zhang M; Yu L; Shi Y
    Mol Biol Rep; 2022 May; 49(5):3939-3947. PubMed ID: 35449318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.
    Zhang X; Niu W; Mu M; Hu S; Niu C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA DLGAP1-AS2 modulates glioma development by up-regulating YAP1 expression.
    Miao W; Li N; Gu B; Yi G; Su Z; Cheng H
    J Biochem; 2020 Apr; 167(4):411-418. PubMed ID: 31899508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. lncRNA DLGAP1-AS2 Knockdown Inhibits Hepatocellular Carcinoma Cell Migration and Invasion by Regulating miR-154-5p Methylation.
    Chen K; Zhang Z; Yu A; Li J; Liu J; Zhang X
    Biomed Res Int; 2020; 2020():6575724. PubMed ID: 33195697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long noncoding RNA DLGAP1-AS2 facilitates cholangiocarcinoma progression via miR-505 and GALNT10.
    Liu Z; Pan L; Yan X; Duan X
    FEBS Open Bio; 2021 Feb; 11(2):413-422. PubMed ID: 33301605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.
    Dou X; Wang Z; Lu W; Miao L; Zhao Y
    BMC Pulm Med; 2022 Aug; 22(1):324. PubMed ID: 36008805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m
    Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G
    J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N
    Huang T; Cao L; Feng N; Xu B; Dong Y; Wang M
    Bioengineered; 2021 Dec; 12(2):10935-10944. PubMed ID: 34866525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.